Jay Cui, a former director at AbbVie Ventures, the investment subsidiary of pharmaceutical group AbbVie, has joined life science-focused investment firm Abingworth as principal.
The role will involve Cui sourcing and evaluating new investment opportunities at the firm as well as supporting its existing portfolio. At AbbVie, he was involved in equity investments in early-stage biotechnology developers and was a board observer at several of the unit’s portfolio companies.
Cui was previously a business strategy consultant on the life sciences sector at management consulting and professional services firm ZS Associates from 2015 to 2017. He also spent a stint at management consulting business Campbell Alliance.
Cui worked as an associate at a $20m venture philanthropy fund for spinouts from University of Chicago and Argonne National Labs in 2013, according to his Linkedin profile.
Abingworth has also announced the appointment of Lucille Conroy as a principal. She was previously a senior associate from investment and financial services group Fidelity’s F-Prime Capital unit. Diya Malhotra, a former life science consultant at LEK Consulting, has joined the firm as an investment manager.
Cui will operate out of Abingworth’s California office in Menlo Park, while Conroy and Malhotra will be based in London.
Photo of Jay Cui courtesy of LinkedIn.